Itamar Medical Receives FDA Approval for Sleep Apnea Monitor
The newly approved product is a one-use, $100 version of the company’s existing product, which retails for $5,000
Established in 1997 in Israeli coastal town Caesarea, Itamar Medical develops and manufactures non-invasive diagnostic devices for sleep disorders and cardiovascular diseases.
The newly approved product, WatchPAT One, is a one-use version of the company’s existing product, WatchPAT 300. While the previous product’s data could only be extracted in a lab, the new product synchronizes the data in real time with the user’s phone via an app. While the previous product, still available on the market, costs $5,000, the one-use version retails for $100.